Schonfeld Strategic Advisors LLC Ionis Pharmaceuticals Inc Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 371,381 shares of IONS stock, worth $12.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
371,381
Previous 362,888
2.34%
Holding current value
$12.3 Million
Previous $14.5 Million
10.69%
% of portfolio
0.08%
Previous 0.11%
Shares
17 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$547 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$470 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$381 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$343 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$288 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.71B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...